IgA-type macroprolactin among 130 patients with macroprolactinemia

IgA-type macro-PRL was demonstrated to exist. IgG-type macro-PRL was most prevalent, followed by IgA, non-IgA/non-IgG and IgA plus IgG-type macro-PRLs.

Authors

Institutions

Publication Details

Journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2025-04-08
DOI
https://doi.org/10.1515/cclm-2025-0264
Citations
3
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
4.08
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IgA-type macroprolactin among 130 patients with macroprolactinemia

Takashi Adachi, Norito Nishiyama, Takanori Saito, Masayuki Ishihara et al.
3 citations
Clinical Chemistry and Laboratory Medicine (CCLM)
Monoclonal and Polyclonal Antibodies Research
4.08
article

IgA-type macroprolactin among 130 patients with macroprolactinemia

Takashi Adachi, Norito Nishiyama, Takanori Saito, Masayuki Ishihara, Naoki Hattori, Kozo Aisaka
article en
3 citations

Abstract

IgA-type macro-PRL was demonstrated to exist. IgG-type macro-PRL was most prevalent, followed by IgA, non-IgA/non-IgG and IgA plus IgG-type macro-PRLs.

Clinical Chemistry and Laboratory Medicine (CCLM)Vol. 63(9)
Kansai Medical University (JP)
Clean water and sanitation
Openalex Percentile: Top 7%
Monoclonal and Polyclonal Antibodies Research
4.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.